Article Text

Download PDFPDF
Review
Endoscopic assessment and management of biliary strictures
  1. M F Dawwas1,2,
  2. K W Oppong2,
  3. G J Webster3
  1. 1Division of Digestive Diseases and Nutrition, Department of Medicine, University of Kentucky Medical Center, Lexington, Kentucky, USA
  2. 2Department of Gastroenterology, Freeman Hospital, Newcastle upon Tyne, UK
  3. 3Department of Gastroenterology, University College Hospital, London, UK
  1. Correspondence to Dr K W Oppong, Hepato-Pancreato-Biliary Unit, Freeman Hospital, Freeman Road, Newcastle upon Tyne NE7 7DN, UK; kofi.oppong{at}nuth.nhs.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Introduction

Strictures of the biliary tract represent a common diagnostic and management problem in pancreaticobiliary practice, often requiring close multidisciplinary collaboration among endoscopists, surgeons, radiologists, pathologists and oncologists. The underlying aetiologies, clinical manifestations and prognostic significance are protean, encompassing both benign and malignant entities; single and multifocal disease distributions; extrahepatic and intrahepatic site involvement; silent and symptomatic presentations, and clinically indolent as well as rapidly progressive natural histories. From a practical standpoint, however, the most critical distinction to make, both accurately and expeditiously, is between benign and malignant aetiologies since timely surgical resection of early-stage malignant disease remains the only route to cure. Definitive differentiation, however, is not always feasible, and many cases remain indeterminate even after extensive investigation.

The differential diagnosis of biliary strictures is predominantly a function of geography and consequent variations in disease epidemiology. In the Western world, most biliary strictures are secondary to malignant disease in the form of pancreatic cancer, cholangiocarcinoma, gallbladder cancer, malignant hilar lymphadenopathy and hepatocellular carcinoma. Important benign aetiologies include iatrogenic causes (usually in the setting of bile duct injury during cholecystectomy) chronic pancreatitis, primary sclerosing cholangitis (PSC) and immunoglobulin G-subfraction 4 (IgG4)-related sclerosing cholangitis (IgG4-SC). Other causes of benign biliary strictures include gallstone disease (choledocholithiasis or Mirizzi syndrome); ischaemic and non-ischaemic injury in the setting of liver transplantation; anastomotic disease after biliary tract surgery; abdominal trauma; percutaneous therapy of hepatocellular carcinoma (radiofrequency or ethanol ablation and chemoembolisation); radiotherapy; portal bilopathy, vasculitides; and miscellaneous infections (such as recurrent pyogenic cholangitis, cytomegalovirus infection and human immunodeficiency virus).

The clinical manifestations of biliary strictures are equally diverse, principally dictated by the severity of luminal obstruction and nature of causative disease process, ranging from being entirely asymptomatic with or without biochemical or radiological features of cholestasis, as in many post-cholecystectomy bile duct injuries, to those of …

View Full Text

Footnotes

  • Contributors MFD wrote the first draft; all authors contributed to the final manuscript.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.